Infectious Disease Advisor Contributing Writer, Author at Infectious Disease Advisor

Infectious Disease Advisor Contributing Writer

All articles by Infectious Disease Advisor Contributing Writer


DAA Therapy Associated With Higher Survival in HCV-Related Comorbidities

Patients with hepatitis C virus (HCV) and comorbidities, including hepatocellular carcinoma (HCC), clinically significant portal hypertension, and cirrhosis were shown to have significantly higher survival rates when treatment included directly acting antiviral agent (DAA) therapy, according to the results of several studies presented at the American Association for the Study of Liver Diseases’ The Liver…

doctor on computer

New EMR-Based Tools Improve Hepatitis Screening in Various Care Settings

New diagnostic tools used to identify hepatitis C virus (HCV) and hepatitis B virus (HBV) utilize simple questionnaires and emergency medical records (EMR) to alert physicians in both primary care and high-volume care settings about patients at risk for viral hepatitis infection or reactivation. The results of these studies were presented at the American Association…

Active Hepatocellular Carcinoma as a Risk Factor for DAA Treatment Failure

Active hepatocellular carcinoma was associated with nonsustained virologic response, while inactive hepatocellular carcinoma was not, suggesting that it is beneficial to defer direct-acting antiviral (DAA) treatment until after a complete radiological response, according to a study published in PLoS One. A recent systematic review and meta-analysis reported that active hepatocellular carcinoma is associated with DAA treatment…

Next post in Hepatitis Advisor